Stem cell transplantation has been used for the first time to treat diabetes in Gansu province
Recently, the Anning branch of lanzhou military region general hospital adopted stem cell transplantation technology for the first time to treat 2 patients with diabetes. After the operation, after more than a month of observation, the two patients were in good health, the blood glucose index was basically normal, and the symptoms such as blurred vision, poor sleep and tingling of the legs and feet were also significantly improved.
Stem cell transplantation is a new technology in the treatment of diabetes in the world. At present, many medical institutions at home and abroad are carrying out clinical trials, and anning branch of lanzhou military region general hospital takes the lead in carrying out this technology in our province. Lin Yunxin, director of the hospital endocrinology, stem cell is a self-replicating and multi-directional differentiation potential of the primitive cells that form the body of various tissues and organs of the primitive cells, stem cell transplantation for the treatment of diabetes, is the equivalent of two minimally invasive surgery under local anesthesia, its principle is through the transplant autologous stem cells, repair the pancreas function, induction of endogenous insulin secretion increased, improve insulin sensitivity. According to the clinical experience at home and abroad, this technique has the advantages of low risk, non-toxic side effects, high safety, less trauma and high treatment efficiency. Apart from a few people with blood coagulation dysfunction, severe infectious disease, lung disease can not tolerate surgery, with other Ⅰ, Ⅱ and there are complications of diabetes, can be the technical treatment of diabetes.
Recently, the hospital conducted a second batch of stem cell transplantation for 4 diabetic patients.
- June 18, 2019The treatment of diabetes has always been mainly based on drugs, but with the development of the disease, the dosage increases and the curative effect becomes worse, in particular, the life condition ...view
- March 25, 2019March 5, 2019 / Bio Valley BIOON / -- Cancer immunotherapy giant Merck & Co recently announced that the European Medicines Agency (EMA) Human Pharmaceutical Products Committee (CHMP) has issued po...view
- June 18, 2019Beijing, May 16 (xinhua The third annual meeting of the Chinese bone marrow bank (CMM) and the 10th anniversary celebration of the restart of the CMM bank were held on June 16. The CMM bank has a capa...view